Sun Zhenyu, Zhao Jiahao, Fan Siwen, Huang Xingyu, Fu Hao, Liu Haiyan, Sun Wen, Zhou Zihui, Wu Danlian, Zhu Xia
Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou, Jiangsu Province, China.
Department of Pharmacy, The Jiangyin Clinical College of Xuzhou Medical University, Xuzhou, Jiangyin, China.
Endocrine. 2025 Aug 30. doi: 10.1007/s12020-025-04394-6.
This study investigated the protective role of Perilipin 5 (PLIN5) in pancreatic β-cell dysfunction under diabetic conditions, focusing on its regulatory effects on lipid metabolism and mitochondrial dynamics.
Diabetic db/db mice and pancreatic beta cell line INS-1 were employed to investigate the role of PLIN5 in insulin secretion and lipid metabolism under high glucose (HG) conditions. The phenotypic changes were evaluated by staining and measurement of biochemical indexes. The molecular mechanism was explored by biological techniques such as Western blotting, qPCR, immunofluorescence and lentivirus infection.
PLIN5 was decreased under diabetic conditions which was related to lipid accumulation in the pancreas. The in vitro knockdown of PLIN5 promoted apoptosis in INS-1 cells, leading to a reduction in insulin secretion mediated by lipid accumulation. PLIN5 knockdown also promoted mitochondrial dysfunction in normal-glucose-cultured INS-1 cells mainly through decreasing PGC-1α and increasing Drp1 levels. In contrast, PLIN5 overexpression reversed the damage caused by HG in INS-1 cells, such as increased apoptosis and lipid accumulation, mitochondrial dysfunction and weakened capacity of insulin secretion. PLIN5 overexpression also blunted the inhibitory effects of HG on PGC-1α and Drp1 expressions. The reduced expression of PLIN5 also led to decreased binding of PGC-1α to the promoter region of Drp1.
Our data indicate that PLIN5 acts as a potent regulator of lipid accumulation in pancreatic β cells treated with HG through the modulation of PGC-1α and Drp1.
本研究调查了 perilipin 5(PLIN5)在糖尿病条件下对胰腺β细胞功能障碍的保护作用,重点关注其对脂质代谢和线粒体动力学的调节作用。
使用糖尿病 db/db 小鼠和胰腺β细胞系 INS-1 来研究 PLIN5 在高糖(HG)条件下对胰岛素分泌和脂质代谢的作用。通过染色和生化指标测量评估表型变化。采用蛋白质免疫印迹、qPCR、免疫荧光和慢病毒感染等生物技术探索分子机制。
糖尿病条件下 PLIN5 降低,这与胰腺中的脂质积累有关。体外敲低 PLIN5 促进 INS-1 细胞凋亡,导致脂质积累介导的胰岛素分泌减少。敲低 PLIN5 还主要通过降低 PGC-1α 和增加 Drp1 水平促进正常葡萄糖培养的 INS-1 细胞中的线粒体功能障碍。相反,PLIN5 过表达逆转了 HG 对 INS-1 细胞造成的损伤,如凋亡增加、脂质积累、线粒体功能障碍和胰岛素分泌能力减弱。PLIN5 过表达还减弱了 HG 对 PGC-1α 和 Drp1 表达的抑制作用。PLIN5 表达降低还导致 PGC-1α 与 Drp1 启动子区域的结合减少。
我们的数据表明,PLIN5 通过调节 PGC-1α 和 Drp1,作为 HG 处理的胰腺β细胞中脂质积累的有效调节因子。